Significant Ownership of AI Biotechnology LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for AI Biotechnology LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Alejandro Moreno - By: Access Industries Management, LLC, its Manager; its Executive Vice President/Alejandro Moreno
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow AI Biotechnology LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from AI Biotechnology LLC
Significant Ownership of AI Biotechnology LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | Class A Common Stock, par value $0.0001 per share | 20% | $24,001,644 | 9,091,532 | AI Biotechnology LLC | 31 Mar 2026 | ||
| ZURA | Zura Bio Limited | Class A Ordinary Shares, par value $0.0001 per share | 18% | $103,223,132 | +$28,154,420 | 19,699,071 | +38% | AI Biotechnology LLC | 26 Feb 2026 |
| SRZN | Surrozen, Inc. | Common stock, par value $0.00001 per share | 9.9% | $8,462,521 | 844,563 | AI Biotechnology LLC | 24 Mar 2025 | ||
| Yarrow Bioscience, Inc. | Common Stock, par value $0.0001 per share | 6% | 178,180 | AI Biotechnology LLC | 27 Jul 2026 |
Schedules 13D/G Reported by AI Biotechnology LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.